Your only treatment of mesothelioma news source!
Click on each item to read full story.

 
Pennsylvania Mesothelioma Victims Center Now Offers Victims In Pennsylvania Instant Access To The Nation's Top ...
read story
The Pennsylvania Mesothelioma Victims Center is now expanding their victim's initiative in the Keystone State to now include instant access to the nation's most skilled mesothelioma compensation attorneys, who are also licensed to practice law in Pennsylvania, and medical doctors instate who specialize in the treatment of mesothelioma. For more information about these new services, a diagnosed ...
 
New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma
read story
Japanese doctors say they may have found a way around the toxicity problem of standard drug treatment for mesothelioma. (PRWeb October 25, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12272045.htm
 
Castle Biosciences’ Multi-Analyte Test Successfully Identifies Esophageal Cancer Patients Who Are Extremely Resistant ...
read story
Castle Biosciences Inc. today announced that results from a second validation study of its proprietary multi-analyte test, DecisionDx-EC, confirmed the test’s ability to identify which esophageal cancer patients are unlikely to benefit from the standard pre-surgical treatment of chemoradiation.
 
New Mexico Mesothelioma Victims Center Begins A New Initiative Focused On Ensuring Diagnosed Victims Who Are Ex ...
read story
The New Mexico Mesothelioma Victims Center has launched a new initiative focused on making certain diagnosed victims of mesothelioma in New Mexico, or their family members have instant access to the nation's most skilled mesothelioma compensation attorneys, especially if the diagnosed victim was exposed to asbestos while working at a military base or at a power plant. For more information a ...
 
Press Release
read story
Castle Biosciences Inc. Posted on: 23 Oct 14 Castle Biosciences Inc. today announced that results from a second validation study of its proprietary multi-analyte test DecisionDx-EC confirmed the test’s ability to identify which esophageal cancer patients are unlikely to benefit from the standard pre-surgical treatment of chemoradiation.
 
Aduro Presents Updated Interim Results from Phase 1b Clinical Trial in Mesothelioma at International Mesothelioma ...
read story
Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced the presentation of updated safety and efficacy data from an ongoing Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma .
 
Verastem Presents New Data on Mesothelioma Programs at the 12th International Mesothelioma Interest Group Meeting
read story
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of clinical and preclinical data in oral presentation and discussion sessions at the 12th International Mesothelioma Interest Group (iMig) Conference being held October 22-24, 2014, at the Cape Town ...
 
Mesothelioma Victims Center Points To New Research Showing A Common Asian Spice Combined With Cancer-Hampering ...
read story
This week the Mesothelioma Victims Center is sharing new research from a Science Daily article that shows how a common Asian spice, in combination with cancer-hampering molecules, might slow the progression of mesothelioma. For more information about the most up-to-date treatment options, as well as information about the nation's most skilled mesothelioma compensation attorneys, diagnosed ...
 
Mesothelioma Victims Center Urges Diagnosed Victims Nationwide To Check Out Philadelphia's Fox Chase Cancer Center's ...
read story
While the Mesothelioma Victims Center might best be known for their efforts to make certain all diagnosed victims of mesothelioma get the best possible compensation for this asbestos related form of cancer, they are increasingly trying to create public awareness about top-notch cancer treatment centers in the United States that specialize in the treatment of mesothelioma. This week the group is ...
 
Aduro BioTech Announces Interim Phase 1B Clinical Data of CRS-207 for the Treatment of Mesothelioma Accepted for Oral ...
read story
Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced that interim data from the Phase 1B clinical trial of its CRS-207 cancer immunotherapy in combination with ch